CF
47
5
ADBE
50
3
MTB
38
4
JNPR
59
3
LRCX
56
4
SRE
37
9
LB
16
9
CRM
65
6
AEE
51
3
VNO
46
6
NDAQ
46
2
MDT
59
4
SJM
17
5
MRK
25
2
ILMN
31
4
GOOG
77
14
CI
35
2
NKE
36
2
INTC
35
4
VRSK
54
2
CF
47
5
ADBE
50
3
MTB
38
4
JNPR
59
3
LRCX
56
4
SRE
37
9
LB
16
9
CRM
65
6
AEE
51
3
VNO
46
6
NDAQ
46
2
MDT
59
4
SJM
17
5
MRK
25
2
ILMN
31
4
GOOG
77
14
CI
35
2
NKE
36
2
INTC
35
4
VRSK
54
2
Financhill
Back

LuxUrban Hotels Vs. Novo Nordisk AS Industry Stock Comparison

Sell
21

LUXH
LuxUrban Hotels

Last Price:
$1.00
Seasonality Move:
-5.56%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
21
LuxUrban Hotels (LUXH) is a Sell

Is LuxUrban Hotels a Buy, Sell or Hold?

  • The current LuxUrban Hotels [LUXH] share price is $1.00. The Score for LUXH is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • LUXH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LUXH Stock Price Chart

What is LuxUrban Hotels's stock price today?

  • The LuxUrban Hotels share price today is $1.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LUXH is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

LUXH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 38.99 Sell
Chaikin Money Flow: -175326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.65 - 1.67) Sell
Bollinger Bands (100): (1.93 - 5.93) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

LUXH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.81 Buy
20-day SMA: 0.96 Buy
50-day SMA: 2.3 Sell
200-day SMA: 28.43 Sell
8-day EMA: 0.91 Buy
20-day EMA: 1.15 Sell
50-day EMA: 2.52 Sell
200-day EMA: 46.85 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

LuxUrban Hotels Earnings Growth & LUXH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $17.80 per share, and an increase next year of $0.30 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

LuxUrban Hotels Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):